BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 21, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for June 8, 2026

June 8, 2026
New hires and promotions in the biopharma and med-tech industries, including: Abcellera, Genovyn, Livanova, Tempest.
Read More

Appointments and advancements for June 5, 2026

June 5, 2026
New hires and promotions in the biopharma and med-tech industries, including: Alera, Beyondspring, Quanterix.
Read More

Appointments and advancements for June 4, 2026

June 4, 2026
New hires and promotions in the biopharma and med-tech industries, including: Celularity, Cocrystal, Corrixr, Cue Biopharma, Defence, Jenavalve, Natera, Neuronetics, Noah, Ovid, Precision, Transverse.
Read More

Appointments and advancements for June 3, 2026

June 3, 2026
New hires and promotions in the biopharma and med-tech industries, including: Airna, Altessa, Enyo, Evotec, Fundamental, Kazia, Minerva, Oncolytics Biotech, Prokidney, Rocket One, Spyglass, Tavo.
Read More

Appointments and advancements for June 2, 2026

June 2, 2026
New hires and promotions in the biopharma and med-tech industries, including: Actinium, Aditxt, Defence, Fractyl, Lungpacer.
Read More

Appointments and advancements for June 2, 2026

June 2, 2026
New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Pharmaessentia.
Read More

Appointments and advancements for June 1, 2026

June 1, 2026
New hires and promotions in the biopharma and med-tech industries, including: Allogene, Immunogenesis, Intuitive, Panther.
Read More

Appointments and advancements for May 29, 2026

May 29, 2026
New hires and promotions in the biopharma and med-tech industries, including: Alto Neuroscience, Aptevo, Brainstorm Cell, Briya, Compass Pathways, Countable Labs, Enplusone, Pharmaessentia, Topadur, Treos, Zentalis.
Read More

Appointments and advancements for May 28, 2026

May 28, 2026
New hires and promotions in the biopharma and med-tech industries, including: Clearnote Health, Immunic, Indupro, Micron, Nocion, Nuvalent, Octave, Retension.
Read More

Appointments and advancements for May 27, 2026

May 27, 2026
New hires and promotions in the biopharma and med-tech industries, including: Breezebio, Decoy, Delphia, Metriopharm, Verastem.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 326 327 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • Wireframe of feet and scale

    GLP-1s need technologies for long-term use

    BioWorld
    For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
  • UTRN gene involved in arthrogryposis, study finds

    BioWorld Science
    Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
  • Blue-gray dollar sign

    HMNC raises $50M series B to prep depression drugs for phase III

    BioWorld
    HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
  • Illustration of glucose in the blood stream

    CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

    BioWorld Science
    Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing